Literature DB >> 19633781

Depression in children and adolescents.

Claudia Mehler-Wex1, Michael Kölch.   

Abstract

INTRODUCTION: Prevalence rates for depression in children and adolescents are estimated up to 8.9%. Symptoms in this age group are different from those of depression in adults. Both neurobiological and psychosocial factors are involved in its development.
METHODS: Selective literature review.
RESULTS: Of note are both the high rate of spontaneous remissions in childhood (33%), and the high rate of depressions continuing into adulthood (80%). In addition far fewer evidence based treatments are available than for adults. Fluoxetine is currently the only medication licensed for use in children and adolescents for this indication. Tri- and tetracyclic antidepressants have not been shown in meta-analyses to be effective in children and adolescents. Most antidepressants lead to age related side effects, including attention deficit and in particular behavioral toxicity, which has to be taken seriously wherever there is a suicide risk. DISCUSSION: The treatment of depression in childhood and adolescence should be based on multimodal interventions including psychotherapy, including cognitive behavioral therapy, which has proven effectiveness, psychosocial interventions and medications in severe cases. Patients with severe depression, especially suicidal minors, should be treated in patients units.

Entities:  

Keywords:  depression; mental disorder; pediatric disease; serotonin reuptake inhibitor; suicide

Year:  2008        PMID: 19633781      PMCID: PMC2696739          DOI: 10.3238/arztebl.2008.0149

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  26 in total

1.  Sertraline improves symptoms in children and adolescents with major depressive disorder.

Authors:  Erin B McClure; Ellesn Leibenluff; Daniel S Pine
Journal:  Evid Based Ment Health       Date:  2004-02

2.  Distinct mechanism for antidepressant activity by blockade of central substance P receptors.

Authors:  M S Kramer; N Cutler; J Feighner; R Shrivastava; J Carman; J J Sramek; S A Reines; G Liu; D Snavely; E Wyatt-Knowles; J J Hale; S G Mills; M MacCoss; C J Swain; T Harrison; R G Hill; F Hefti; E M Scolnick; M A Cascieri; G G Chicchi; S Sadowski; A R Williams; L Hewson; D Smith; E J Carlson; R J Hargreaves; N M Rupniak
Journal:  Science       Date:  1998-09-11       Impact factor: 47.728

Review 3.  [Reflections on the psychobiology of depression].

Authors:  J Aldenhoff
Journal:  Nervenarzt       Date:  1997-05       Impact factor: 1.214

4.  A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy.

Authors:  D A Brent; D Holder; D Kolko; B Birmaher; M Baugher; C Roth; S Iyengar; B A Johnson
Journal:  Arch Gen Psychiatry       Date:  1997-09

5.  Nocturnal ACTH, cortisol, growth hormone, and prolactin secretion in prepubertal depression.

Authors:  M D De Bellis; R E Dahl; J M Perel; B Birmaher; M al-Shabbout; D E Williamson; B Nelson; N D Ryan
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-09       Impact factor: 8.829

6.  Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

Authors:  John March; Susan Silva; Stephen Petrycki; John Curry; Karen Wells; John Fairbank; Barbara Burns; Marisa Domino; Steven McNulty; Benedetto Vitiello; Joanne Severe
Journal:  JAMA       Date:  2004-08-18       Impact factor: 56.272

Review 7.  [Medical treatment of depression in children and adolescents].

Authors:  Michael Kölch; Jörg M Fegert
Journal:  Prax Kinderpsychol Kinderpsychiatr       Date:  2007

8.  Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials.

Authors:  Karen Dineen Wagner; Paul Ambrosini; Moira Rynn; Christopher Wohlberg; Ruoyong Yang; Michael S Greenbaum; Ann Childress; Craig Donnelly; Deborah Deas
Journal:  JAMA       Date:  2003-08-27       Impact factor: 56.272

Review 9.  Recent advances in the neurobiology of depression.

Authors:  Charles B Nemeroff
Journal:  Psychopharmacol Bull       Date:  2002

10.  Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.

Authors:  Robert D Gibbons; C Hendricks Brown; Kwan Hur; Sue M Marcus; Dulal K Bhaumik; Joëlle A Erkens; Ron M C Herings; J John Mann
Journal:  Am J Psychiatry       Date:  2007-09       Impact factor: 18.112

View more
  9 in total

1.  Motor abnormalities, depression risk, and clinical course in adolescence.

Authors:  Katherine S F Damme; Jadyn S Park; Teresa Vargas; Sebastian Walther; Stewart A Shankman; Vijay A Mittal
Journal:  Biol Psychiatry Glob Open Sci       Date:  2021-07-03

Review 2.  [Off-label use in child and adolescent psychiatry. An ongoing ethical, medical and legal problem].

Authors:  M Kölch; M Allroggen; J M Fegert
Journal:  Nervenarzt       Date:  2009-07       Impact factor: 1.214

3.  Depressive Symptoms in Adolescents.

Authors:  Lutz Wartberg; Levente Kriston; Rainer Thomasius
Journal:  Dtsch Arztebl Int       Date:  2018-08-20       Impact factor: 5.594

4.  Impact of Physical Exercise on Symptoms of Depression and Anxiety in Pre-adolescents: A Pilot Randomized Trial.

Authors:  Arnaud Philippot; Alexandre Meerschaut; Laura Danneaux; Gauthier Smal; Yannick Bleyenheuft; Anne G De Volder
Journal:  Front Psychol       Date:  2019-08-08

5.  Efficacy of Motivational Interviewing to Improve Utilization of Mental Health Services Among Youths With Chronic Medical Conditions: A Cluster Randomized Clinical Trial.

Authors:  Christina Reinauer; Anna Lena Platzbecker; Rabea Viermann; Matthias Domhardt; Harald Baumeister; Katharina Foertsch; Hannah Linderskamp; Lisa Krassuski; Doris Staab; Kirsten Minden; Reinhold Kilian; Reinhard W Holl; Petra Warschburger; Thomas Meißner
Journal:  JAMA Netw Open       Date:  2021-10-01

6.  Risks and Resources for Depressive Symptoms and Anxiety in Children and Adolescents During the COVID-19 Pandemic - Results of the Longitudinal COPSY Study.

Authors:  Neslihan Güzelsoy; Ulrike Ravens-Sieberer; Joachim Westenhöfer; Janine Devine; Michael Erhart; Heike Hölling; Anne Kaman
Journal:  Front Psychiatry       Date:  2022-07-07       Impact factor: 5.435

7.  Morning light therapy for juvenile depression and severe mood dysregulation: study protocol for a randomized controlled trial.

Authors:  Sarah Bogen; Tanja Legenbauer; Thorsten Bogen; Stephanie Gest; Thomas Jensch; Silvia Schneider; Martin Holtmann
Journal:  Trials       Date:  2013-06-17       Impact factor: 2.279

Review 8.  Treatment of Major Depressive Disorder in Pediatric Populations.

Authors:  Drew R Neavin; Jeremiah Joyce; Cosima Swintak
Journal:  Diseases       Date:  2018-06-04

9.  [Acute treatment of psychiatric ill children and adolescents: A pilot study on 257 patients].

Authors:  Teresa Eichinger; Elisabeth Marte; Leonhard Thun-Hohenstein; Franz Santner; Belinda Plattner
Journal:  Neuropsychiatr       Date:  2021-03-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.